Home / LINCOLN.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does LINCOLN.NS make money? Does LINCOLN.NS have pricing power? What's the Earnings Whisper? Will LINCOLN.NS profit more as the business scales? What is LINCOLN.NS's management track record? Is LINCOLN.NS's current price justified?

Lincoln Pharmaceuticals Limited

₹545.6 +$65.80 (+13.71%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹555

Day Range

₹540.7₹559.1

Year Range

₹440₹770

Market Cap

10.93B

AVG Volume

47K

Trailing/Forward PE

11.33/20.31

PEG ratio

0.63

Dividend Yield

0.33%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

LINCOLN.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	2.02B
26 Q4	1.87B
26 Q3	1.66B
26 Q2	1.63B
26 Q1	1.54B
25 Q4	1.68B
25 Q3	1.47B
25 Q2	1.61B
25 Q1	1.47B
24 Q4	1.42B

Net Income (INR) · Q

LINCOLN.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	362.35M
26 Q4	116.35M
26 Q3	286M
26 Q2	199.84M
26 Q1	276.75M
25 Q4	115.75M
25 Q3	207.69M
25 Q2	263.3M
25 Q1	236.72M
24 Q4	185.97M

Operating Income (INR) · Q

LINCOLN.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	830.93M
26 Q4	211.72M
26 Q3	198.75M
26 Q2	218.09M
26 Q1	203.27M
25 Q4	234.93M
25 Q3	204.39M
25 Q2	251.54M
25 Q1	195.08M
24 Q4	-190.19M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Lincoln Pharmaceuticals Limited

Video analysis: LINCOLN.NS

News: LINCOLN.NS

Similar companies